RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- December 06, 2006 -- SCYNEXIS, Inc., a chemistry-focused drug discovery and development company, today announced that it has entered into a multi-year research agreement with Merck & Co., Inc. to discover and develop novel oncology compounds.
